Immunization therapy in Alzheimer's disease

Felix Mor; Alon Monsonego

doi:10.1586/14737175.6.5.653

Immunization therapy in Alzheimer's disease

Felix Mor^*, Alon Monsonego

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Review article › peer-review

Abstract

Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

Original language	English
Pages (from-to)	653-659
Number of pages	7
Journal	Expert Review of Neurotherapeutics
Volume	6
Issue number	5
DOIs	https://doi.org/10.1586/14737175.6.5.653
State	Published - 2006

Keywords

Alzheimer's disease
Clinical trials
Meningoencephalitis
Th1/Th2 balance
Vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1586/14737175.6.5.653

Cite this

@article{04da4d9d6de34034aaf10ad67c4b18ac,

title = "Immunization therapy in Alzheimer's disease",

abstract = "Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.",

keywords = "Alzheimer's disease, Clinical trials, Meningoencephalitis, Th1/Th2 balance, Vaccination",

author = "Felix Mor and Alon Monsonego",

year = "2006",

doi = "10.1586/14737175.6.5.653",

language = "אנגלית",

volume = "6",

pages = "653--659",

journal = "Expert Review of Neurotherapeutics",

issn = "1473-7175",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Immunization therapy in Alzheimer's disease

AU - Mor, Felix

AU - Monsonego, Alon

PY - 2006

Y1 - 2006

N2 - Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

AB - Alzheimer's disease (AD) is a common and devastating neurodegenerative disease. The incidence of AD is increasing in Western societies. The current treatment of AD is mostly symptomatic and ineffective in stopping or reversing the cognitive impairment. One of the exciting and effective new treatments developed in experimental AD is immunization against amyloid-β peptide. This article provides an overview of immunization therapy in AD and examines the future prospects of this therapeutic modality.

KW - Alzheimer's disease

KW - Clinical trials

KW - Meningoencephalitis

KW - Th1/Th2 balance

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=33745062869&partnerID=8YFLogxK

U2 - 10.1586/14737175.6.5.653

DO - 10.1586/14737175.6.5.653

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 16734513

AN - SCOPUS:33745062869

SN - 1473-7175

VL - 6

SP - 653

EP - 659

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

IS - 5

ER -

Immunization therapy in Alzheimer's disease

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this